Publications by authors named "Jeffrey Brindle"

Claim this Profile
E
Early and multiple PSA bounces can occur following high-dose prostate stereotactic body radiation therapy: Subset analysis of a phase 1/2 trial.
D Nathan Kim, Christopher Straka, L Chinsoo Cho, Yair Lotan, Jingsheng Yan, Jeffrey Brindle

Pract Radiat Oncol· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereotactic body radiation therapy for low and intermediate risk prostate cancer-Results from a multi-institutional clinical trial.
Raquibul Hannan, Vasu Tumati, Xian-Jin Xie, L Chinsoo Cho, Brian D Kavanagh, Jeffrey Brindle

Eur J Cancer· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of rectal tolerance observed in a dose-escalated phase 1-2 trial of stereotactic body radiation therapy for prostate cancer.
D W Nathan Kim, L Chinsoo Cho, Christopher Straka, Alana Christie, Yair Lotan, Jeffrey Brindle

Int J Radiat Oncol Biol Phys· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I dose-escalation study of stereotactic body radiation therapy for low- and intermediate-risk prostate cancer.
Thomas P Boike, Yair Lotan, L Chinsoo Cho, Jeffrey Brindle, Paul DeRose

J Clin Oncol· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results of a planned interim toxicity analysis with trimodality therapy, including carboplatin AUC = 4, paclitaxel, 5-fluorouracil, amifostine, and radiation for locally advanced esophageal cancer: preliminary analyses and treatment recommendations from the North Central Cancer Treatment Group.
Aminah Jatoi, James Martenson, Michelle R Mahoney, Bradley S Lair, Jeffrey S Brindle

Int Semin Surg Oncol· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis